Innovation in Diagnostic Imaging Services. Assessing the Potential for Value-based Reimbursement

Academic Radiology

Volumn 18, Issue 9, 2011, Pages 1109-1114

  Garrison, Louis P ^a   Bresnahan, Brian W ^b   Higashi, Mitchell K ^c   Hollingworth, William ^d   Jarvik, Jeffrey G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c GE HEALTHCARE   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cost effectiveness; Diagnostic imaging; Dynamic efficiency; Innovation; Price controls; Value based pricing; Value based reimbursement

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; MEDICARE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PRODUCTIVITY; REIMBURSEMENT;

DIAGNOSTIC IMAGING; DIFFUSION OF INNOVATION; DRUG DISCOVERY; FEE SCHEDULES; GREAT BRITAIN; HUMANS; MEDICARE; MODELS, ECONOMIC; REIMBURSEMENT MECHANISMS; RELATIVE VALUE SCALES; UNITED STATES;

EID: 79960974233     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.04.007     Document Type: Article

References (21)

1. Greenspan A. Payment setup can't ensure that Medicare's fit. The Wall Street Journal September 4, 1984.
2. Arrow K.J. Economic welfare and the allocation of research for invention. The rate and direction of inventive activity: economic and social factors 1961, Princeton University Press, Princeton, NJ. R. Nelson (Ed.).
3. Jena A.B., Philipson T. Cost-effectiveness as a price control. Health Aff (Millwood) 2007, 26:696-703.
4. Garrison L.P., Mansley E.C., Abbott T.A., et al. Good research practices in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report-part II. Value Health 2010, 13:8-13.
5. Raab G.G., Parr D.H. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology-part 1: issues in medical device assessment. J Am Coll Radiol 2006, 3:694-702.
6. Hsiao W.C., Braun P., Dunn D., et al. Results and policy implications of the resource-based relative-value study. N Engl J Med 1988, 319:881-888.
7. Garrison L.P. Rewarding value creation to promote innovation in the oncology: the importance of considering the global product life cycle. Oncologist 2010, 15(suppl):49-57.
8. Jena A.B., Philipson T.J. Innovation and technology adoption in health care markets 2008, AEI Press, Washington, DC.
9. Newhouse J.P. How much should Medicare pay for drugs?. Health Aff (Millwood) 2004, 23:89-102.
10. Hackbarth GM. MedPAC recommendations on imaging services. Statement before the Subcommittee on Health, Committee on Energy and Commerce, U.S. House of Representatives, July 18, 2006.
11. ®. J Am Coll Radiol 2008, 5:630-635.
12. ®" J Am Coll Radiol 2008, 5:636-637.
13. The pharmaceutical price regulation scheme: an OFT market study 2007, Office of Fair Trading, Office of Fair Trading, London, United Kingdom.
14. Coombes R. Briefing: NICE and value based pricing: what do we know?. BMJ 2010, 341:c6390.
15. UK Department of Health. Fact sheet: value-based pricing and NICE. Available at: Accessed December 27, 2010. http://www.dh.gov.uk/en/MediaCentre/Factsheets/DH_121652?PageOperation=email#_9.
16. UK Department of Health. A new value-based approach to the pricing of branded medicines: a consultation. Available at: Accessed April 1, 2011. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_122793.pdf.
17. Wilensky G.R. Developing a center for comparative effectiveness information. Health Aff (Millwood) 2006, 25:w572-w585.
18. Iglehart J.K. Prioritizing comparative effectiveness research-IOM recommendations. N Engl J Med 2009, 361:325-328.
19. Pandharipande P.V., Gazelle G.S. Comparative effectiveness research: what it means for radiology. Radiology 2009, 253:600-605.
20. Clancy C., Collins F.S. Patient-centered outcomes research institute: the intersection of science and health care. Sci Transl Med 2010, 2. 37cm18.
21. Otero H.J., Rybicki F.J., Greenberg D., et al. Twenty years of cost utility analysis in medical imagining: are we improving?. Radiology 2008, 249:735.